臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"pu y s"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 1-25 of 627 (26 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2022-09-15T01:09:59Z	A pilot study of AFL-T (doxorubicin, 5-fluorouracil, leucovorin, and tamoxifen) combination chemotherapy for hormone-refractory prostate cancer	Chia-Chi Lin; Hsu C.-H.; Chen J.; Tsai T.-C.; Cheng A.-L.; Pu Y.-S.
臺大學術典藏	2022-09-15T01:09:58Z	Changing trends of prostate cancer in Asia	Pu Y.-S.; Chiang H.-S.; Chia-Chi Lin; Huang C.-Y.; Huang K.-H.; Chen J.
臺大學術典藏	2022-09-15T01:09:58Z	Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide	Hour T.-C.; Huang C.-Y.; Chia-Chi Lin; Chen J.; Guan J.-Y.; Lee J.-M.; Pu Y.-S.
臺大學術典藏	2022-09-15T01:09:57Z	Differential expression of molecular markers in arsenic- and non-arsenic-related urothelial cancer	Hour T.-C.; Pu Y.-S.; Chia-Chi Lin; Huang S.-W.; Chen J.; Chiu A.W.; Chen C.-J.; Huang C.-Y.
臺大學術典藏	2022-09-15T01:09:57Z	Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells	Pu Y.-S.; Hsieh M.-W.; Wang C.-W.; Liu G.-Y.; Huang C.-Y.; Chia-Chi Lin; Guan J.-Y.; Lin S.-R.; Hour T.-C.
臺大學術典藏	2022-09-15T01:09:56Z	Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity	Chia-Chi Lin; Hsu C.-H.; Huang C.-Y.; Cheng A.-L.; Chen J.; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏	2022-09-15T01:09:56Z	Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma	Chia-Chi Lin; Hsu C.-H.; Huang C.-Y.; Cheng A.-L.; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏	2022-09-15T01:09:56Z	Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: A two-case study	Chia-Chi Lin; Hsu C.-H.; Pu Y.-S.
臺大學術典藏	2022-09-15T01:09:54Z	Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study	Chia-Chi Lin; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; Pu Y.-S.
臺大學術典藏	2022-09-15T01:09:54Z	Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens	Chia-Chi Lin; Hsu C.-H.; Huang C.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; Pu Y.-S.
臺大學術典藏	2022-09-15T01:09:53Z	Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial	Chia-Chi Lin; Hsu C.-H.; Hour T.-C.; Cheng A.-L.; Huang C.-Y.; Huang K.-H.; Chen J.; Pu Y.-S.
臺大學術典藏	2022-09-15T01:09:52Z	Systemic therapy for metastatic urothelial carcinoma	Chia-Chi Lin; Hsu C.-H.; Pu Y.-S.; Vogelzang N.J.
臺大學術典藏	2022-09-15T01:09:51Z	Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma	Chia-Chi Lin; Pu Y.-S.; Hsu C.-H.; Keng H.-Y.; Cheng A.-L.; Yang C.-H.
臺大學術典藏	2022-09-15T01:09:51Z	Down-regulated expression of RhoA in human conventional renal cell carcinoma	Pu Y.-S.; Wang C.-W.; Liu G.-Y.; Kuo Y.-Z.; Huang C.-Y.; Kang W.-Y.; Shun C.-T.; Chia-Chi Lin; Wu W.-J.; Hour T.-C.
臺大學術典藏	2022-09-15T01:09:04Z	Nuclear factor-κB overexpression is correlated with poor outcomes after multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer	Chiang Y.; Wang C.-C.; Tsai Y.-C.; Huang C.-Y.; Pu Y.-S.; Chia-Chi Lin; Cheng J.C.-H.
臺大學術典藏	2022-09-06T08:56:53Z	Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions	Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; Lin B.-R.; MING-SHIANG WU; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Hsieh C.-Y.
臺大學術典藏	2022-07-12T01:43:17Z	Major complications and associated risk factors of transrectal ultrasound guided prostate needle biopsy: A retrospective study of 1875 cases in Taiwan	Chiang I.-N.; SHANG-JEN CHANG; Pu Y.-S.; Huang K.-H.; Yu H.-J.; Huang C.-Y.
臺大學術典藏	2022-07-12T01:43:14Z	Comparison of 6- and 12-core prostate biopsy in Taiwanese men: Impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection	Chiang I.-N.; SHANG-JEN CHANG; Pu Y.-S.; Huang K.-H.; Yu H.-J.; Huang C.-Y.
臺大學術典藏	2022-07-12T01:43:13Z	Diagnostic Value of Finger-guided Prostate Nodule Biopsy Combined With Systemic Random Biopsy	Chiang I.-N.; SHANG-JEN CHANG; Pu Y.-S.; Huang K.-H.; Yu H.-J.; Huang C.-Y.
臺大學術典藏	2022-05-10T08:09:52Z	Comparative efficacy and safety of new surgical treatments for benign prostatic hyperplasia: Systematic review and network meta-analysis	Huang S.-W.; Tsai C.-Y.; Tseng C.-S.; Shih M.-C.; Yeh Y.-C.; Chien K.-L.; Pu Y.-S.; YU-KANG TU
臺大學術典藏	2022-05-09T06:25:43Z	Extranodal extension predicts poor survival outcomes among patients with bladder cancer	Liao Y.-A.; Chiang C.-J.; WEN-CHUNG LEE; Zhuang B.-Z.; Chen C.-H.; Pu Y.-S.
臺大學術典藏	2022-05-05T08:48:55Z	The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer	Wang Y.-J.; Huang C.-Y.; Hou W.-H.; CHIA-CHUN WANG; Lan K.-H.; Chen C.-H.; Yu H.-J.; Lai M.-K.; Cheng A.-L.; Liu S.-P.; Pu Y.-S.; Cheng J.C.-H.
臺大學術典藏	2022-05-05T08:48:55Z	Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation	Hou W.-H.; Huang C.-Y.; CHIA-CHUN WANG; Lan K.-H.; Chen C.-H.; Yu H.-J.; Liu S.-P.; Lai M.-K.; Pu Y.-S.; Cheng J.C.-H.
臺大學術典藏	2022-05-05T08:48:55Z	Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy	Wang Y.-J.; Huang C.-Y.; Hou W.-H.; CHIA-CHUN WANG; Lan K.-H.; Yu H.-J.; Lai M.-K.; Liu S.-P.; Pu Y.-S.; Cheng J.C.-H.
臺大學術典藏	2022-05-05T08:48:54Z	Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma	Hsu F.-M.; Hou W.-H.; Huang C.-Y.; CHIA-CHUN WANG; Tsai C.-L.; Tsai Y.-C.; Yu H.-J.; Pu Y.-S.; Cheng J.C.-H.

Showing items 1-25 of 627 (26 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2809385
	???header.visitor??? : 26947705 ???header.onlineuser??? : 472 ???header.sponsordeclaration???